CCCC – c4 therapeutics, inc. (US:NASDAQ)
Stock Stats
News
C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)
C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma
Analysts See Significant Upside in C4 Therapeutics (CCCC) Stock [Yahoo! Finance]
C4 Therapeutics Details MOMENTUM Phase 2 Start, Eyes Near-Term Decision on EGFR Program at Barclays Confab [Yahoo! Finance]
C4 Therapeutics, Inc. (CCCC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Form 8-K C4 Therapeutics, Inc. For: Apr 10
Form 8-K C4 Therapeutics, Inc. For: Apr 09
Form 4 C4 Therapeutics, Inc. For: Apr 01 Filed by: Anderson Kenneth Carl
Form 4 C4 Therapeutics, Inc. For: Apr 01 Filed by: GROGAN DONNA ROY
Form 144 C4 Therapeutics, Inc. Filed by: Siegel Jolie
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.